tiprankstipranks
Trending News
More News >
Assertio Therapeutics Inc (ASRT)
NASDAQ:ASRT
US Market

Assertio Therapeutics (ASRT) Ratios

Compare
1,124 Followers

Assertio Therapeutics Ratios

ASRT's free cash flow for Q1 2025 was $0.71. For the 2025 fiscal year, ASRT's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.39 1.83 1.39 0.77 0.71
Quick Ratio
1.24 1.43 1.24 0.71 0.62
Cash Ratio
0.68 0.79 0.68 0.27 0.16
Solvency Ratio
0.76 -2.05 0.76 0.12 >-0.01
Operating Cash Flow Ratio
0.82 0.53 0.82 0.04 -0.49
Short-Term Operating Cash Flow Coverage
167.23 0.00 167.23 0.45 -5.49
Net Current Asset Value
$ -55.93M$ 22.65M$ -55.93M$ -120.64M$ -153.51M
Leverage Ratios
Debt-to-Assets Ratio
0.16 0.14 0.16 0.23 0.28
Debt-to-Equity Ratio
0.30 0.30 0.30 0.72 1.51
Debt-to-Capital Ratio
0.23 0.23 0.23 0.42 0.60
Long-Term Debt-to-Capital Ratio
0.23 0.22 0.23 0.37 0.57
Financial Leverage Ratio
1.83 2.08 1.83 3.19 5.46
Debt Service Coverage Ratio
17.91 -88.86 17.91 1.70 0.51
Interest Coverage Ratio
7.26 -72.05 7.26 0.92 -2.95
Debt to Market Cap
0.33 0.51 0.33 0.78 2.23
Interest Debt Per Share
1.59 0.62 1.59 1.94 3.82
Net Debt to EBITDA
0.03 0.15 0.03 0.95 -19.76
Profitability Margins
Gross Profit Margin
88.00%82.23%88.00%85.74%81.30%
EBIT Margin
24.89%-165.14%24.89%8.71%-27.84%
EBITDA Margin
46.43%-146.28%46.43%34.93%-3.01%
Operating Profit Margin
37.00%-160.15%37.00%8.49%-44.15%
Pretax Profit Margin
19.95%-167.06%19.95%-0.50%-42.83%
Net Profit Margin
70.17%-218.28%70.17%-1.15%-26.48%
Continuous Operations Profit Margin
70.17%-218.28%70.17%-1.15%-26.48%
Net Income Per EBT
351.75%130.66%351.75%231.65%61.84%
EBT Per EBIT
53.91%104.32%53.91%-5.87%97.01%
Return on Assets (ROA)
26.49%-115.89%26.49%-0.39%-9.28%
Return on Equity (ROE)
48.57%-240.53%48.57%-1.25%-50.70%
Return on Capital Employed (ROCE)
18.15%-126.20%18.15%4.92%-27.50%
Return on Invested Capital (ROIC)
63.66%-164.10%63.66%10.61%-15.66%
Return on Tangible Assets
50.77%-189.59%50.77%-1.16%-27.27%
Earnings Yield
54.24%-436.75%54.24%-1.36%-74.57%
Efficiency Ratios
Receivables Turnover
3.44 3.19 3.44 2.50 2.40
Payables Turnover
3.13 2.01 3.13 2.37 1.34
Inventory Turnover
1.37 0.72 1.37 2.11 1.70
Fixed Asset Turnover
209.99 74.58 209.99 72.70 43.61
Asset Turnover
0.38 0.53 0.38 0.34 0.35
Working Capital Turnover Ratio
57.60 2.65 57.60 -3.17 -1.79
Cash Conversion Cycle
255.97 441.94 255.97 164.39 95.45
Days of Sales Outstanding
105.96 114.40 105.96 145.85 152.32
Days of Inventory Outstanding
266.64 509.08 266.64 172.66 215.12
Days of Payables Outstanding
116.64 181.54 116.64 154.12 271.99
Operating Cycle
372.61 623.48 372.61 318.51 367.44
Cash Flow Ratios
Operating Cash Flow Per Share
1.67 0.70 1.67 0.13 -2.50
Free Cash Flow Per Share
1.67 0.69 1.67 0.13 -2.50
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 0.99 1.00 0.99 1.00
Dividend Paid and CapEx Coverage Ratio
286.85 78.99 286.85 104.21 -6.56K
Capital Expenditure Coverage Ratio
286.85 78.99 286.85 104.21 -6.56K
Operating Cash Flow Coverage Ratio
1.18 1.21 1.18 0.08 -0.78
Operating Cash Flow to Sales Ratio
0.50 0.33 0.50 0.05 -0.62
Free Cash Flow Yield
38.75%64.44%38.75%5.81%-173.77%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
1.84 -0.23 1.84 -73.46 -1.34
Price-to-Sales (P/S) Ratio
1.29 0.50 1.29 0.85 0.36
Price-to-Book (P/B) Ratio
0.90 0.55 0.90 0.92 0.68
Price-to-Free Cash Flow (P/FCF) Ratio
2.58 1.55 2.58 17.20 -0.58
Price-to-Operating Cash Flow Ratio
2.57 1.53 2.57 17.04 -0.58
Price-to-Earnings Growth (PEG) Ratio
>-0.01 <0.01 >-0.01 0.76 0.01
Price-to-Fair Value
0.90 0.55 0.90 0.92 0.68
Enterprise Value Multiple
2.81 -0.20 2.81 3.37 -31.54
Enterprise Value
204.05M 43.47M 204.05M 130.79M 101.06M
EV to EBITDA
2.81 -0.20 2.81 3.37 -31.54
EV to Sales
1.31 0.29 1.31 1.18 0.95
EV to Free Cash Flow
2.61 0.89 2.61 23.91 -1.54
EV to Operating Cash Flow
2.60 0.88 2.60 23.68 -1.54
Tangible Book Value Per Share
0.59 0.38 0.59 -2.63 -5.52
Shareholders’ Equity Per Share
4.80 1.94 4.80 2.37 2.12
Tax and Other Ratios
Effective Tax Rate
-2.52 -0.31 -2.52 -1.32 0.38
Revenue Per Share
3.32 2.14 3.32 2.57 4.05
Net Income Per Share
2.33 -4.67 2.33 -0.03 -1.07
Tax Burden
3.52 1.31 3.52 2.32 0.62
Interest Burden
0.80 1.01 0.80 -0.06 1.54
Research & Development to Revenue
0.00 0.02 0.00 0.00 0.04
SG&A to Revenue
0.28 0.43 0.28 0.49 0.98
Stock-Based Compensation to Revenue
0.05 0.06 0.05 0.03 0.10
Income Quality
0.72 -0.15 0.72 -4.31 2.33
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis